ABOUT US | MedXCell is a Swiss/French start-up studio specialising in cell therapy. It is dedicated to transforming healthcare through the development and production of new therapies utilizing the unique healing powers of living cells. The start-up studio aims to identify high-potential academic assets, mature them in-house rapidly with the operational team and the access to GLP/GMP facility for fast proof-of-concept and provide the project with the right capital resources. MedXCell invested and matured a number of projects among which CYTEA|BIO and BIORESPX.
0
Countries
0
Sites
+0
Million Raised
+0
Employees
TEAM | MedXCell’s Management and Board bring a wealth of big Pharma, Academic and Biotech / entrepreneurial expertise

EXPERIENCED SENIOR EXECUTIVES

LAURENT ZBINDEN

Serial entrepreneur and former. CEO of multiple companies with more than 30 years experience.

LIONEL BRODARD

Manager with experience in start-ups and biotech (Celgene). HEC, HSG & EPFL training.

ALAN COOKSON, PHD

Over 40 years of experience in the pharmaceutical and healthcare industry. Founder of several biotechnology start-ups.

SUPPORTED BY A WORLD CLASS INTERNATIONAL BOARD OF DIRECTORS

LAURENT ZBINDEN

Serial entrepreneur and former. CEO of multiple companies with more than 30 years experience.

JOHN MCMANNIS, PHD

Former Head of Manufacturing at Mesoblast (NASDAQ: MESO). Ex- Professor at UTMD Anderson Cancer Center. Led the Cell Therapy Laboratory at UTMD and designed its facility.

ANH NGUYEN, PHD

Co-founder and Chairman of MedinCell (EPA:MEDCL). Co- founder of Syntro (NASDAQ 1987) and Invitrogen (NASDAQ 1999). Invitrogen was acquired by Thermo Fisher in 2013 for $16bn.

ANDREW GALAZKA, M.D.

Highly experienced drug developer and regulatory strategist (Merck KGaA, Serono, GSK and Biogen). Formerly SVP Clinical Development at Merck and Serono with a strong track record of drug approvals

Gabriel Baertschi

CEO of the Grünenthal Group (€ 1,4B Sales, 4’700 employees in 2019). Previously Company President of AstraZeneca Japan and Germany. Managed brands in immuno-oncology.

J.-J. DE DARDEL, PHD

Non-executive director. Formerly Ambassador to The People’s Republic of China, to Mongolia and the DPRK (2014-2019). Previously Ambassador to France and Monaco (2011-2014).

PARTNERSHIPS | The MedXCell Group enjoys close relationships with academic and business partners, who contribute strongly to the Group’s capabilities.  Academic partnerships are important for scientific discovery and establishment of future product concepts, providing a pipeline of new ideas and intellectual property.  The Group has additional business partnerships which enable full corporate operations on a global basis. The MedXCell Group highly values its collaborations with synergistic organizations and individuals and prides itself in making collaborative work exceed the sum of the parts.

University Hospital Center of Montpellier (CHU)

The Montpellier Hospitals have a history spanning 1’000 years. It was in the 20th century that close collaboration between universities and hospitals culminated in the creation of the University Hospital Centers (CHUs) in France. The fundamental missions of the University Hospital Center of Montpellier today are care, teaching, and research.  It is organized around 13 university hospital centers grouping all medical and surgical specialties and spread over several geographical sites in Montpellier.

Institute for Regenerative Medicine & Biotherapy (IRMB)

Located at, and operating in close collaboration the CHU of Montpellier is the Institute of Regenerative Medicine and Biotherapies (IRMB), which is dedicated to research on adult and embryonic stem cells, including both basic biological aspects and innovative applications of regenerative therapy. On a single site, fundamental research, hospital laboratories and private companies are gathered around common technical platforms and infrastructures in health biology dedicated to stem cells.

IRM B, CHU MONTPELLIER, Insitut Médecine Régénératrice

University of Montpellier

The University of Montpellier (UM) is the 6th largest university in France, with about 50,000 students. One of the most innovative higher education institutions in the world, UM was credited as the most innovative French university in 2018 Reuter’s ranking. The University of Montpellier provides World-Class research teams with state-of-the-art equipment and shared technological platforms.

Federal Polytechnical School of Lausanne (EPFL)

EPFL is Europe’s most cosmopolitan technical university. It welcomes students, professors and collaborators of more than 120 nationalities. EPFL has both a Swiss and international vocation and focuses on three missions: teaching, research and innovation.  EPFL collaborates with an important network of partners, including other universities and colleges, secondary schools, industry and the economy, political circles and the general public, with the aim of having a real impact on society.

Cambridge Innovation Center (CIC)

Cambridge Innovation Center in Massachusetts is a global leader in building and operating innovation communities. The MedXCell Group has chosen CIC to be its base for North America.